Interleukin-4 gene therapy - University of PittsburghAlternative Names: S4-IL4
Latest Information Update: 20 Nov 2007
At a glance
- Originator University of Pittsburgh
- Class Cytokine genes; Gene therapies; Interleukins
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Cancer pain
Most Recent Events
- 16 Jun 2003 Preclinical trials in Cancer pain in USA (unspecified route)